Abstract
This research service covers the U.S. asthma/COPD market from 2003-2013.
Included are a therapeutic overview, patient forecasts, total market revenue
forecasts, market segment revenue forecasts, and market share analysis. The
market is segmented by product class: bronchodilators, anti-inflammatories,
and combination therapies. Major market challenges, drivers, restraints, and
strategic recommendations to overcome market challenges are also discussed.
Table of Contents
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- Overview
- Scope and Segmentation
- Research Methodology
- Disease Overview
- Asthma
- COPD
- Treatment Options
- Market Overview
- Market Engineering Measurements
- Industry Challenges and Strategic Recommendations
- Market Drivers
- Market Restraints
3 TOTAL MARKET ANALYSIS
- Competitive Analysis
- Patient Forecasts
- Patient Forecasts - Asthma
- Patient Forecasts - COPD
- Total Patient Forecasts
- Revenue Forecasts
- Total Market Revenue Forecasts
- Market Share Analysis
4 BRONCHODILATORS MARKET
- Introduction
- Introduction
- Market Engineering Measurements
- Revenue Forecasts
- Market Share Analysis
- Short-Acting Beta-2 Agonists Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Long-Acting Beta-2 Agonists Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Anticholinergics Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Combination Bronchodilators
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
5 ANTI-INFLAMMATORY MARKET
- Introduction
- Introduction
- Market Engineering Measurements
- Revenue Forecasts
- Market Share Analysis
- Inhaled Corticosteroids Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Mediator-Release Inhibitor Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Anti-Leukotriene Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Monoclonal Antibody Market
- Introduction
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
- Other Emerging Anti-Inflammatories
6 COMBINATION THERAPIES MARKET
- Combination Therapies
- Introduction
- Market Engineering Measurements
- Revenue Forecasts
- Product Analysis
- Pipeline Analysis
7 APPENDIX
- Decision Support Databases
- Mortality Due to Asthma Bronchitis and Emphysema
- Prevalence of Asthma
- Prevalence of Chronic Obstructive Pulmonary Disease
- Female Population 65 and Above
- Male Population 65 and Above
| 
